CCEL - Cryo-Cell International, Inc.
| Previous Close | 7.296 |
| Open | 0.000 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's Range | 0.000 - 0.000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 1,315 |
| Market Cap | 51.839M |
| Beta | -0.13 |
| PE Ratio (TTM) | 24.32 |
| EPS (TTM) | 0.300 |
| Earnings Date | Apr 12, 2018 - Apr 16, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- GlobeNewswire•6 days ago
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2018 Financial Results
OLDSMAR, Fla., April 16, 2018-- Cryo-Cell International, Inc., the world’ s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended ...
- GlobeNewswire•2 months ago
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2017
OLDSMAR, Fla., Feb. 28, 2018-- Cryo-Cell International, Inc., the world’ s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, ...
Capital Cube•6 months agoCryo-Cell International, Inc. :CCEL-US: Earnings Analysis: Q3, 2017 By the Numbers : October 17, 2017
Categories: Yahoo FinanceGet free summary analysis Cryo-Cell International, Inc. reports financial results for the quarter ended August 31, 2017. Highlights Summary numbers: Revenues of USD 6.90 million, Net Earnings of USD 0.50 million. Gross margins narrowed from 74.87% to 70.84% compared to the same period last year, operating (EBITDA) margins now 21.90% from 14.06%. Change in operating ... Read more (Read more...)
Capital Cube•9 months agoCryo-Cell International, Inc. :CCEL-US: Earnings Analysis: Q2, 2017 By the Numbers : July 10, 2017
Categories: Yahoo FinanceGet free summary analysis Cryo-Cell International, Inc. reports financial results for the quarter ended May 31, 2017. Highlights Summary numbers: Revenues of USD 6.24 million, Net Earnings of USD 0.50 million. Gross margins narrowed from 74.49% to 73.96% compared to the same period last year, operating (EBITDA) margins now 20.02% from 16.55%. Change in operating ... Read more (Read more...)